1. Introduction {#sec1-molecules-20-19819}
===============

Natural products isolated/extracted from medicinal plants have high potential as new bioactive compounds. As a result, molecules with both low molecular weight (e.g., quinones, cerebrosides, isoflavones, catechol, amines, terpenes, steroids, *etc.*) and high molecular weight (e.g., polysaccharides, glycoproteins, glycopeptides, proteins, *etc.*) have been investigated as putative pharmaceutical agents \[[@B1-molecules-20-19819]\].

*Helleboreus* spp. (family *Ranunculaceae*) are spontaneous perennial flowering herb plants. In the Romanian spontaneous flora, there are two species of hellebore: *Helleborus purpurascens* and *Helleborus odorus*, both of them flowering in early spring \[[@B2-molecules-20-19819],[@B3-molecules-20-19819]\]. *Helleborus purpurascens* is extremely toxic, yet known since long ago for its folkloric therapeutic effects. It has been used in traditional medicine since ancient times for the treatment of various diseases: pain, mental and cardiac disorders, *etc.* References on the therapeutic use of this herb go back to the time of Hippocrates. In the Middle Ages, the physician and alchemist Paracelsus prepared and proposed an extract of *Helleborus* as an "elixir" to increase life expectancy \[[@B4-molecules-20-19819]\]. The Romanian researcher Boici used a purified hellebore extract for the preparation of a pharmaceutical product named Boicil, which showed therapeutic activity in rheumatic diseases \[[@B5-molecules-20-19819]\]. The plant extract is used as an anti-rheumatic ointment without any previous investigation of the activity of the individual components of hellebore, therefore, the component(s) responsible for the biological activity of Boicil have not been identified yet. However, recent studies on the antitumor, immune and biological activity of *Helleborus* extracts revealed the multitude of directions in this field of research targeting the elucidation of the biological potential and cellular mechanisms addressed by various components from this plant \[[@B6-molecules-20-19819],[@B7-molecules-20-19819],[@B8-molecules-20-19819]\]. Some of the main components of *Helleborus purpurascens* are glycosides, thionins (helleborine, hellebrine), saponides, resins, lactones, protoanemonine, and minerals \[[@B6-molecules-20-19819],[@B7-molecules-20-19819],[@B8-molecules-20-19819],[@B9-molecules-20-19819],[@B10-molecules-20-19819]\].

The significance of studying the structure of natural peptides was illustrated by numerous pharmacological investigations, identifying various essential properties of these types of compounds such as their low molecular mass, their relatively unique and simple structures, low antigenicity, low toxicity, and an highly biological activity because of their remarkable chemical diversity, steric complexity and high biochemical specificity \[[@B1-molecules-20-19819],[@B11-molecules-20-19819],[@B12-molecules-20-19819],[@B13-molecules-20-19819]\]. Peptide properties depend on the constituent amino acids and the amino acid sequences in the peptide structure. Modern chemistry offers various methods for biochemical and structural analysis of peptides and glycopeptides. Chromatography and mass spectrometry proved to be efficient techniques for the identification of each component from a complex natural matrix \[[@B14-molecules-20-19819]\].

Thionins are relatively small-sized multiple-cysteine peptides with antimicrobial properties due to their high content of cysteine units \[[@B15-molecules-20-19819]\]. The antitumor and immunomodulating activities of hellebore are attributed to the cytotoxicity of this natural peptide \[[@B15-molecules-20-19819],[@B16-molecules-20-19819],[@B17-molecules-20-19819],[@B18-molecules-20-19819],[@B19-molecules-20-19819]\]. Although there are many studies worldwide on hellebore extracts and their biological activities, research in this area continues to be of great interest because the chemical structure and composition of *Helleborus purpurascens* have not been fully elucidated yet \[[@B6-molecules-20-19819],[@B20-molecules-20-19819],[@B21-molecules-20-19819],[@B22-molecules-20-19819],[@B23-molecules-20-19819]\]. The aim of this study was hence to isolate the amino acids and thionins from an alcoholic extract of *Helleborus purpurascens*, identify them using spectroscopic and chromatographic techniques and to test their biological activity in terms of antiproliferative effects.

2. Results and Discussion {#sec2-molecules-20-19819}
=========================

A mandatory step toward separation of target compounds in an extract is the development of an appropriate partition scheme sequence for phytochemicals, employing different types of solvents, in order to remove metabolites and unwanted compounds, such as: lipids, phenols, detergents, resins, lactones, protoanemonins. Depending on the polarity of the solvent used, there emerges a wide distribution of phytochemicals from the hellebore extract in the different fractions recovered \[[@B24-molecules-20-19819],[@B25-molecules-20-19819],[@B26-molecules-20-19819],[@B27-molecules-20-19819]\].

2.1. HPLC Analysis {#sec2dot1-molecules-20-19819}
------------------

The presence of amino acids in hellebore extracts was examined using HPLC. The influence of the solvent (polarity) on the amino acid content in the analyzed samples (S~1~, S~4~, S~5~ and S~6~) was also taken under consideration. Hence, a qualitative reverse phase HPLC analysis (RP-HPLC) for free amino acids was investigated. Under the same chromatographic conditions, a phenylisothiocyanate (PITC) pre-column derivatization method for standard amino acids was developed. The derivatization step, as a widely used procedure for HPLC analysis of amino acids and peptides, is not necessary if chromatography aims only at separating the amino acids. Comparison of the results of the pre-column PITC derivatization methods for HPLC analysis with those of the RP-HPLC analysis of the hellebore extract could identify its amino acid composition. The proposed RP-HPLC method enabled identification of the amino acids existing in the hellebore fractions S~1~, S~4~, S~5~ and S~6~ (see [Table 1](#molecules-20-19819-t001){ref-type="table"}).

The developed RP-HPLC method allowing for separation and identification of the amino acids in the hellebore extract (S~1~, S~4~, S~5~ and S~6~) is based on the retention times of the used standards.

molecules-20-19819-t001_Table 1

###### 

RP-HPLC identification of *Helleborus purpurascens* amino acids.

  Hellebore Fraction   Amino Acids   Retention Time (Tr) (min)   Peak Area (mAu·min)   Peak High (mAu)   Relative Area
  -------------------- ------------- --------------------------- --------------------- ----------------- ---------------
  S~1~ (ethanolic)     Cys           6.319                       19.7050               48.247            12.79
  His                  7.21          0.6849                      13.520                5.00              
  Phe                  7.978         9.4757                      15.515                6.15              
  Thr                  8.923         0.9001                      3.720                 5.95              
  Glu                  9.958         6.4976                      10.478                4.22              
  Asn                  22.301        108.2632                    130.637               88.89             
  Ala                  32.290        117.4534                    110.475               76.25             
  S~4~ (CH~2~Cl~2~)    Gly           6.987                       0.7801                3.567             2.39
  His                  7.21          0.85                        14.359                4.23              
  Phe                  7.89          7.854                       21.464                6.43              
  Glu                  9.958         6.891                       11.872                5.27              
  Ser                  12.892        1.5890                      9.671                 13.561            
  Asn                  22.301        9.376                       5.701                 8.429             
  Pro                  29.862        1.8539                      2.257                 23.13             
  Ala                  32.290        0.9369                      1.457                 9.22              
  Lys                  35.802        3.2473                      3.401                 19.28             
  Tyr                  39.347        0.5518                      0.743                 8.37              
  S~5~ (*n*-butanol)   Gly           6.987                       8.627                 8.672             10.391
  His                  7.21          0.9138                      12.188                14.57             
  Phe                  7.978         5.624                       9.297                 4.61              
  Glu                  9.958         0.5390                      0.948                 7.94              
  Arg                  13.680        0.5313                      0.860                 17.19             
  Val                  25.068        0.7673                      0.754                 14.83             
  Ala                  32.523        0.3391                      0.382                 9.97              
  Lys                  35.802        3.287                       11.720                8.134             
  Tyr                  39.347        10.346                      23.581                12.365            
  S~6~ (aqueous)       C-C           6.198                       12.0542               59.209            6.52
  Phe                  7.978         27.659                      56.375                29.991            
  Asp                  23.546        15.7821                     121.368               8.53              
  Ala                  32.523        157.0749                    139.018               54.95             

2.2. GC-MS Analysis {#sec2dot2-molecules-20-19819}
-------------------

The content of hellebore extracts in amino acids and peptides and its dependence on solvent type were confirmed by GC-MS analysis. The obtained chromatograms are shown in [Figure 1](#molecules-20-19819-f001){ref-type="fig"}. The mass spectra of the components from the GC-MS chromatograms were compared with those from the NIST/NBS (National Institute of Standards and Technology/National Bureau of Standards**)** spectral database, and the identified amino acids and peptides are presented in [Table 2](#molecules-20-19819-t002){ref-type="table"}.

The proposed isolation strategy unraveled the influence of solvent polarity on the efficiency of amino acid and peptide separation from the hellebore extract. Thus, the hexane fraction (S~2~) contains the largest number of amino acids, with the fewest compounds separated in the ethanol fraction (S~1~).

molecules-20-19819-t002_Table 2

###### 

GC-MS amino acid identification.

  Hellebore Fraction                   Proposed Structure   Abbreviation    SIM (Selected-Ion Monitoring)
  ------------------------------------ -------------------- --------------- -------------------------------
  S~1~ (ethanol)                       cystine              C-C             41, 42
  glutamic acid                        Glu                  38, 40          
  phenylalanine                        Phe                  56, 57          
  hystidine                            Hys                  84              
  asparagine                           Asn                  155, 69         
  isoleucine                           Ile                  170, 130        
  threonine                            Thr                  180             
  β-alanine                            β-Ala                216, 129        
  S~2~ (hexane)                        glutamic acid        Glu             38, 40
  cystine                              C-C                  41, 42          
  ornitine                             Orn                  59, 60, 61      
  isoleucine                           Ile                  170, 130        
  hystidine                            Hys                  84              
  proline                              Pro                  211             
  valine                               Val                  158, 72         
  β-alanine                            β-Ala                216, 129        
  threonine                            Thr                  180             
  homoserine                           HSER                 102, 128, 143   
  asparagine                           Asn                  155, 69         
  α-aminopimelic acid                  APA                  198, 258, 286   
  arginino-succinic acid               ARG-SUC              326             
  S~3~ (CCl~4~)                        asparagine           Asn             155, 69
  alanine                              Ala                  130, 70         
  glutamic acid                        Glu                  38, 40          
  phenylalanine                        Phe                  59, 60          
  homoserine                           HSER                 102, 128, 143   
  threonine                            Thr                  180             
  lysine                               Lys                  170, 129        
  glicine                              Gly                  116, 74         
  glycyl-glycine (dipeptide)           Gly-Gly              117, 144, 201   
  proline-hydroxyproline (dipeptide)   PHP                  156, 186        
  lysine-alanine (dipeptide)           Lys-Ala              170, 224, 153   
  hystidine                            Hys                  84              
  2,4-diamino-*n*-butyric acid         DABA                 203, 142, 245   
  1-methylhistidine                    1MHIS                298             
  arginino-succinic acid               ARG-SUC              326             
  α-aminopimelic acid                  APA                  198, 258, 286   
  S~4~ (CH~2~Cl~2~)                    valine               Val             158, 72
  β-alanine                            β-Ala                216, 129        
  isoleucine                           Ile                  170, 130        
  glutamic acid                        Glu                  38, 40          
  phenylalanine                        Phe                  59, 60          
  serine                               Ser                  146,9           
  tyrosine                             Tyr                  61, 63          
  proline-hydroxyproline (dipeptide)   PHP                  156, 186        
  lysine                               Lys                  170, 129        
  glycine                              Gly                  116, 74         
  glutamine                            Gln                  83, 186         
  hystidine                            His                  84              
  asparagine                           Asn                  155, 69         
  S~5~ (*n*-butanol)                   glutamic acid        Glu             38, 40
  phenylalanine                        Phe                  59, 60, 76      
  tyrosine                             Tyr                  61, 63, 94      
  hystidine                            His                  84, 115         
  glycine                              Gly                  116, 74         
  lysine                               Lys                  170, 129        
  valine                               Val                  158, 72         

###### 

GC-MS chromatogram for S~1~--S~5~ hellebore extract.

![](molecules-20-19819-g001a)

![](molecules-20-19819-g001b)

2.3. Hellebore Thionins Characterized by GC-MS {#sec2dot3-molecules-20-19819}
----------------------------------------------

The results of the GC-MS for samples S~1T~ (petroleum ether) and S~2T~ (acetone) are shown in [Figure 2](#molecules-20-19819-f002){ref-type="fig"}.

###### 

GC-MS chromatogram for S~1T~ and S~2T~ hellebore extract.

![](molecules-20-19819-g002a)

![](molecules-20-19819-g002b)

The compounds identified by mass spectral interpretation through GC-MS analysis are listed in [Table 3](#molecules-20-19819-t003){ref-type="table"}.

The efficiency of the chosen separation strategy for thionins was evaluated by GC-MS analysis. The results show the influence of solvent polarity on the number of isolated compounds. In the low polarity fraction S~1T~ (petroleum ether); eleven amino acids and one dipeptide were isolated and identified in the GC-MS chromatogram ([Table 3](#molecules-20-19819-t003){ref-type="table"}).

molecules-20-19819-t003_Table 3

###### 

Thionin GC-MS identification.

  Hellebore Fraction                   Proposed Structure   Abbreviation    SIM
  ------------------------------------ -------------------- --------------- --------
  S~1T~ (petroleum ether)              cystine              C-C             41, 42
  histidine                            His                  84, 115         
  tyrosine                             Tyr                  61, 63, 94      
  lysine                               Lys                  170, 129        
  homoserine                           HSER                 102, 128, 143   
  β-alanine                            β-Ala                216, 129        
  leucine                              Leu                  172, 86         
  phenylalanine                        Phe                  59, 60, 76      
  glutamic acid                        Glu                  38, 40          
  glycine                              Gly                  116, 74         
  3-methylcysteine                     \-                   172, 259, 130   
  proline-hydroxyproline (dipeptide)   PHP                  156, 186        
  S~2T~ (acetone)                      cystine              C-C             41, 42
  glutamic acid                        Glu                  38, 40          
  tyrosine                             Tyr                  61, 63, 94      
  valine                               Val                  158, 72         
  β-alanine                            β-Ala                216, 129        
  phenylalanine                        Phe                  59, 60, 76      

2.4. Nano-ESI-Chip-MS Analysis {#sec2dot4-molecules-20-19819}
------------------------------

All five hellebore fractions S~1~--S~5~ were submitted to high-throughput positive nanoESI chip MS and screening under identical solution and instrumental parameters. The obtained mass spectra are illustrated in [Figure 3](#molecules-20-19819-f003){ref-type="fig"}, [Figure 4](#molecules-20-19819-f004){ref-type="fig"}, [Figure 5](#molecules-20-19819-f005){ref-type="fig"}, [Figure 6](#molecules-20-19819-f006){ref-type="fig"}, [Figure 7](#molecules-20-19819-f007){ref-type="fig"}, [Figure 8](#molecules-20-19819-f008){ref-type="fig"} and [Figure 9](#molecules-20-19819-f009){ref-type="fig"}, while the ion fragments and the corresponding amino acids and peptides (assignments to amino acids and peptide structures) are listed in [Table 4](#molecules-20-19819-t004){ref-type="table"}.

![Positive ion mode nano-ESI-Chip-MS forS~1~ hellebore fraction.](molecules-20-19819-g003){#molecules-20-19819-f003}

![Positive ion mode nano-ESI-Chip-MS for S~2~ hellebore fraction.](molecules-20-19819-g004){#molecules-20-19819-f004}

![Positive ion mode nano-ESI-Chip-MS for S~3~ hellebore fraction.](molecules-20-19819-g005){#molecules-20-19819-f005}

![Positive ion mode nano-ESI-Chip-MS for S~4~ hellebore fraction.](molecules-20-19819-g006){#molecules-20-19819-f006}

![Positive ion mode nano-ESI-Chip-MS for S~5~ hellebore fraction.](molecules-20-19819-g007){#molecules-20-19819-f007}

![Positive ion mode nano-ESI-Chip-MS of the hellebore thionins in the petroleum ether fraction.](molecules-20-19819-g008){#molecules-20-19819-f008}

![Positive ion mode nano-ESI-Chip-MS of the hellebore thionins in acetone fraction.](molecules-20-19819-g009){#molecules-20-19819-f009}

molecules-20-19819-t004_Table 4

###### 

Amino acids and peptides species in hellebore fractions detected by MS.

  Hellebore Fraction        Type of Molecular Ion   *m*/*z* Detected   *m*/*z* Calculated            Proposed Structure
  ------------------------- ----------------------- ------------------ ----------------------------- --------------------
  S~1~ (ethanol)            \[M + 2H\]^2+^          149.56             147.18                        Phe
  \[M + 2H\]^2+^            130.71                  128.14             Gln                           
  \[M + 2H\]^2+^            175.58                  173.4              Arg                           
  \[M + NH~3~\]^+^          203.48                  203.14             Tryptophan                    
  \[M + H~2~O + 2H\]^2+^    279.57                  279.34             Cys-Arg                       
  \[M + 2H\]^2+^            317.54                  317.3              Asp-Glu-β-Ala                 
  \[M + 2H\]^2+^            369.66                  369.37             His-Glu-Thr                   
  \[M + H~2~O + 2H\]^2+^    397.66                  397.44             C-C-His                       
  \[M + H\]^+^              429.64                  429.46             Asn-β-Ala-Ile-Glu             
  \[M + H\]^+^              457.65                  457.52             Phe-His-Thr-β-Ala             
  \[M + H~2~O\]             579.59                  579.67             Thr-Phe-Ile-Glu-β-Ala         
  \[M + H~2~O + H^+^        691.62                  691.8              Arg-C-C-Phe-Glu               
  S~2~ (hexane)             \[M + 2H\]^2+^          175.58             173.4                         Arg
  \[M + H~2~O + 2H\]^2+^    192.59                  192.39             β-Ala-Thr                     
  \[M + H~2~O + 2H\]^2+^    397.66                  397.44             C-C-His                       
  \[M + H~2~O + H\]^+^      415.6                   415.48             Glu-Pro-Val-β-Ala             
  \[M + H~2~O + H\]^+^      453.53                  453.5              Ser-His-Ile-Pro               
  \[M + H~2~O + H\]^+^      479.66                  479.54             Apa-Ile-Thr-β-Ala             
  \[M + H~2~O + 2H\]^2+^    523.65                  523.5              Hser-Orn-His-Asn              
  \[M + NH~3~\]^+^          611.65                  611.72             Arg-C-C-Thr-Pro               
  \[M + 2H\]^2+^            655.66                  655.6              Arg-Suc-Asn-HSer-Glu          
  \[M + H~2~O + H\]^+^      743.65                  743.68             Arg-Succ-Asn-HSer-Glu-β-Ala   
  \[M + H~2~O + H\]^+^      729.57                  729.39             Gly-Cystine-Met-Tyr-Hser      
  S~3~ (CCl~4~)             \[M + 2H\]^2+^          149.56             147.18                        Phe
  \[M + H~2~O + 2H\]^2+^    192.59                  192.39             β-Ala-Thr                     
  \[M + H~2~O + 2H\]^2+^    279.57                  279.34             Cys-Arg                       
  \[M + H\]^+^              301.56                  301.56             1MHis-Gly-Gly                 
  \[M + NH~3~\]^+^          381.70                  381.32             Lys-Ala-Phe                   
  \[M + H\]^+^              453.54                  453.44             His-Glu-Asn-β-Ala             
  \[M + H~2~O + H\]^+^      479.66                  479.54             APA-Ile-Thr-β-Ala             
  \[M + H~2~O + 2H\]^2+^    523.65                  523.5              HSer-Orn-His-Asn              
  \[M + H~2~O + H\]^+^      552.98                  552.62             Pro-Hyp-Phe-Thr-Gly           
  \[M + NH~3~\]^+^          611.65                  611.72             Arg-C-C-Thr-Pro               
  \[M + 2H\]^2+^            655.67                  655.6              Arg-Suc-Asn-HSer-Glu          
  \[M + H~2~O + H\]^+^      743.65                  743.68             Arg-Suc-Asn-HSer-Glu-β-Ala    
  \[M + H~2~O + H\]^+^      729.57                  729.39             Gly-Cystine-Met-Tyr-Hser      
  S~4~ (CH~2~Cl~2~)         \[M + 2H\]^2+^          149.56             147.18                        Phe
  \[M + H~2~O + H\]^+^      205.49                  205.42             Val-Ser                       
  \[M + H~2~O + H\]^+^      239.54                  239.27             Gly-Tyr                       
  \[M + H~2~O + 2H\]^2+^    279.57                  279.34             Cys-Arg                       
  \[M + H\]^+^              301.56                  301.56             1MHis-Gly-Gly                 
  \[M + H~2~O + 2H\]^2+^    353.69                  353.39             Gly-Tyr-Ile                   
  \[M + NH~3~\]^+^          381.69                  381.32             Lys-Ala-Phe                   
  \[M + NH~3~\]^+^          413.67                  413.46             Hyp-Lys-His                   
  \[M + H~2~O + H\]^+^      415.6                   415.48             Glu-Pro-Val-β-Ala             
  \[M + H~2~O + H\]^+^      479.66                  479.54             Apa-Ile-Thr-β-Ala             
  \[M + H~2~O + H\]^+^      552.98                  552.62             Pro-Hyp-Phe-Thr-Gly           
  \[M + H~2~O + H\]^+^      579.59                  579.67             Thr-Phe-Ile-Lys-β-Ala         
  \[M + H~2~O + 2H\]^2+^    619.78                  619.80             His-Ser-Val-Tyr-Ile           
  \[M + H~2~O + H\]^+^      691.62                  691.8              Arg-C-C-Phe-Glu               
  \[M + H~2~O + H\]^+^      719.64                  719.80             His -Ser-Val-Tyr-Ile-Thr      
  S~5~ (*n*-butanol)        \[M + 2H\]^2+^          149.56             147.18                        Phe
  \[M + NH~3~\]^+^          203.48                  203.14             Trn                           
  \[M + H\]^+^              301.56                  301.56             1MHis-Gly-Gly                 
  \[M + H~2~O + 2H\]^2+^    353.69                  353.39             Gly-Tyr-Ile                   
  \[M + NH~3~\]^+^          381.69                  381.32             Lys-Ala-Phe                   
  \[M + H~2~O + 2H\]^2+^    523.65                  523.5              HSer-Orn-His-Asn              
  \[M + H~2~O + H\]^+^      579.59                  579.67             Thr-Phe-Ile-Lys-β-Ala         
  \[M + H~2~O + 2H\]^2+^    619.78                  619.80             His-Ser-Val-Tyr-Ile           
  \[M + H~2~O + H\]^+^      691.62                  691.8              Arg-C-C-Phe-Glu               
  S~1T~ (petroleum ether)   \[M + 2H\]^2+^          103.03             103.11                        Thr
  \[M + H\]^+^              104.3                   104.15             Cys                           
  \[M + H\]^+^              185.66                  185.25             β-Ala-Ile                     
  \[M + NH~3~\]^+^          203.48                  203.14             Trn                           
  \[M + NH~3~\]^+^          267.64                  267.34             Phe-Cys                       
  \[M + NH~3~\]^+^          381.69                  381.32             Lys-Ala-Phe                   
  \[M + H~2~O + 2H\]^2+^    511.60                  511.35             3-methyl-Cys-Hyp-Pro-Gln      
  \[M + H~2~O + H\]^+^      552.98                  552.62             Pro-Hyp-Phe-Thr-Gly           
  \[M + H~2~O + H\]^+^      579.59                  579.67             Thr-Phe-Ile-Glu-β-Ala         
  \[M + H~2~O + H\]^+^      691.62                  691.8              Arg-C-C-Phe-Glu               
  \[M + H~2~O + H\]^+^      729.57                  729.39             Gly-C-C-Met-Tyr-HSer          
  S~2T~ (acetone)           \[M + 2H\]^2+^          103.03             103.11                        Thr
  \[M + H\]^+^              104.3                   104.15             Cys                           
  \[M + H\]^+^              185.66                  185.25             β-Ala-Ile                     
  \[M + NH~3~\]^+^          203.48                  203.14             Trn                           
  \[M + NH~3~\]^+^          267.64                  267.34             Phe-Cys                       
  \[M + H~2~O + 2H\]^2+^    288.83                  288.33             Met-His                       
  \[M + H\]^+^              301.56                  301.56             1MHis-Gly-Gly                 
  \[M + H~2~O + 2H\]^2+^    353.69                  353.39             Gly-Tyr-Ile                   
  \[M + NH~3~\]^+^          381.69                  381.32             Lys-Ala-Phe                   
  \[M + H~2~O + 2H\]^2+^    432.69                  432.46             Phe-His-Gly-β-Ala             
  \[M + H~2~O + 2H\]^2+^    523.65                  523.5              HSer-Orn-His-Asn              
  \[M + H~2~O + 2H\]^2+^    527.54                  527.60             Orn-Val-Glu-Phe               
  \[M + H~2~O + H\]^+^      552.98                  552.62             Pro-Hyp-Phe-Thr-Gly           
  \[M + H~2~O + H\]^+^      579.59                  579.67             Thr-Phe-Ile-Glu-β-Ala         
  \[M + H~2~O + H\]^+^      689.55                  689.35             Ile-C-C-Trp-Hyp               
  \[M + H~2~O + H\]^+^      691.62                  691.8              Arg-C-C-Phe-Glu               
  \[M + H~2~O + H\]^+^      729.57                  729.39             Gly-C-C-Met-Tyr-HSer          

To elucidate the chemical composition of the hellebore fractions, we have developed a fully automated new mass spectrometry method based on nanoESI high-capacity ion trap (HCT), in a similar manner as described in the literature \[[@B28-molecules-20-19819]\]. The mass spectrometry results confirmed the chemical structures detected by chromatographic techniques. Although, the developed chromatographic analysis method offered information about the great majority of the chemical species present in the hellebore extracts, mass spectrometry provided many more data on the complexity of the protein structures found in the studied hellebore fractions. Comparison of the screened mass spectra of the hellebore fractions S~1~--S~5~ provided direct evidence of the variable composition of each fraction due, primarily, to the solvent employed. The investigation of thionin composition from the hellebore fractions S~1T~ and S~2T~ highlighted the same compounds identified by previous analytical methods. The information gained from this study corroborates with the existing data from the literature \[[@B29-molecules-20-19819],[@B30-molecules-20-19819]\]. Our results revealed that the proposed methods proved to be useful tools for the separation and identification of individual compounds from complex natural mixtures.

2.5. Biological Activity Investigation {#sec2dot5-molecules-20-19819}
--------------------------------------

The usefulness of timelapse videomicroscopy in the investigation of cell behavior and biological activity of different pharmaceuticals was previously argued upon and proven \[[@B31-molecules-20-19819],[@B32-molecules-20-19819]\]. Here, studies were conducted to assess, in a cancer cell line (HeLa), the effects of two fractions obtained from the alcoholic extract of *Helleborus purpurascens*. As shown in [Figure 10](#molecules-20-19819-f010){ref-type="fig"}, the cells treated with various concentrations of S~5~ ([Figure 10](#molecules-20-19819-f010){ref-type="fig"}A) and S~2T~ ([Figure 10](#molecules-20-19819-f010){ref-type="fig"}D) failed to multiply. The number of mitoses significantly decreased for treated cells for all concentrations used of both S~5~ ([Figure 10](#molecules-20-19819-f010){ref-type="fig"}B) and S~2T~ ([Figure 10](#molecules-20-19819-f010){ref-type="fig"}E). The number of dead cells did not spectacularly increase, although it varied significantly in comparison to untreated cells for both S~5~ ([Figure 10](#molecules-20-19819-f010){ref-type="fig"}C) and S~2T~ ([Figure 10](#molecules-20-19819-f010){ref-type="fig"}F).

![Effects of S~5~ (**A**--**C**) and S~2T~ (**D**--**F**) fractions on HeLa cell behavior monitored by timelapse videomicroscopy. Untreated cells have grown as usual, doubling their number in 24 h (**A**--**D**, control black bars).](molecules-20-19819-g010){#molecules-20-19819-f010}

Both tested fractions (S~5~ and S~2T~) inhibited cell proliferation at significantly low concentrations, as shown by HeLa cell growth in the absence or presence of compounds ([Figure 10](#molecules-20-19819-f010){ref-type="fig"}A,D). Cells that were not treated proliferated and doubled their number after a 24 h monitoring. The number of observed mitoses was significantly higher in the absence of the tested compounds ([Figure 10](#molecules-20-19819-f010){ref-type="fig"}B,E). It is noteworthy that the number of dead cells during the experimental period of 24 h, although significantly increased after treatment, still remained very low ([Figure 10](#molecules-20-19819-f010){ref-type="fig"}C,F), indicating a reduced cytotoxic effect of both fractions S~5~ and S~2T~, isolated from the *Helleborus purpurascens* alcoholic extract. With regard to the dynamics of the identified effects, fraction S~5~ arrested cell division almost completely after 6 h, when the highest concentration was used. For the medium and low concentration, the same effect was observed at about 12 h and beyond. A very interesting result was observed in terms of kinetics of the few mitoses still occurring in the treated samples. If for untreated HeLa cells a starting mitosis succeeded finalizing its cytokinesis stage in no more than half an hour, treated cells starting mitosis needed a significantly longer period until cytokinesis occurred, meaning more than 3 h ([Figure 11](#molecules-20-19819-f011){ref-type="fig"}).

Accordingly, an untreated cell, spread on the culture surface ([Figure 11](#molecules-20-19819-f011){ref-type="fig"}A), started a mitotic process ([Figure 11](#molecules-20-19819-f011){ref-type="fig"}B) and accomplished cytokinesis after 20 min ([Figure 11](#molecules-20-19819-f011){ref-type="fig"}C), whereas the two daughter cells had already spread, 1 h after mitosis has begun ([Figure 11](#molecules-20-19819-f011){ref-type="fig"}D). A treated cell ([Figure 11](#molecules-20-19819-f011){ref-type="fig"}E) that entered mitosis ([Figure 11](#molecules-20-19819-f011){ref-type="fig"}F) needed 200 min to accomplish cytokinesis ([Figure 11](#molecules-20-19819-f011){ref-type="fig"}G), and 90 min more to spread after the mitotic event ([Figure 11](#molecules-20-19819-f011){ref-type="fig"}H), meaning that it needed 4 h and 50 min to finalize a significantly, extremely slow division. This observation supports the conclusion that compounds in both S~5~ and S~2T~ fractions exerted a major antiproliferative effect, recommending them as potential anticancer therapeutic agents. There are very strong evidences on the fact that in those fractions was not identified other molecules, except amino acids and tionins. However, further investigations are needed to assert if the identified biological activity is due exclusively to amino acids, thionins or to other small molecules, as yet not identified by the analytical techniques used.

![Phase contrast micrographs showing cells before, during and at the end of mitosis. Yellow arrowheads indicate cells of interest. (**A**) Control cells before starting any mitosis; (**B**) A control cell is rounding up starting its mitosis; (**C**) The same cell as in (**B**) 20 min later, during cytokinesis; (**D**) The two daughter cells, resulting in mitosis, significantly spread 1 h after mitosis was started; (**E**) Treated cells before starting any mitosis; (**F**) A treated cell rounded up and starting its mitosis; (**G**) The same cell as in (**F**), 200 min later, accomplishing its cytokinesis; (**H**) The daughter cells showing significant spreading 90 min later, that means almost 5 h after mitosis has started. White scale bar in (**E**) represents 50 μm, and is identical for all the images.](molecules-20-19819-g011){#molecules-20-19819-f011}

3. Experimental Section {#sec3-molecules-20-19819}
=======================

3.1. General Information {#sec3dot1-molecules-20-19819}
------------------------

All used reagents were analytical grade. Amino acids were acquired from Applichem (St. Louis, MO, USA) and Alfa Aesar (Ward Hill, MA, USA) and the solvents (methanol, acetone, dichloromethane, carbon tetrachloride, hexane, and *n*-butanol, petroleum ether, ethanol) from VWR (Wien, Austria). Pyridine and phenylisothiocyanate (PITC) were purchased from Alfa Aesar.

Plant roots and rhizomes were collected in February 2011, in Arieseni, Alba (Romania) and identified by Dr. Dana Bobit (vice-president of the Romanian Ethnopharmacology Society, Dacia Plant SRL Brasov, Romania). Voucher samples: 00321 and 00322 were deposited at the Botanical Garden Cluj Napoca, Romania.

3.2. Chromatographic Techniques {#sec3dot2-molecules-20-19819}
-------------------------------

The content of amino acids and peptides from the hellebore samples was analyzed by high performance liquid chromatography (HPLC 3000, Ultimate, Dreieich, Germany) using a photodiode array detector and an EZ: faast 4u AAA-MS Column (250 × 3 mm ID). Qualitative analysis of free amino acids and peptides was performed on a GC-MS 7890A-5975C system (Agilent, Waldbronn, Germany) using the EZ: faast GC-MS free amino acids kit and ZB-AAA GC column (Phenomenex, Torrance, CA, USA). The employed analysis conditions were the standard conditions provided with the kit.

3.3. Spectroscopy Techniques {#sec3dot3-molecules-20-19819}
----------------------------

Mass spectrometry was conducted on a High Capacity Ion Trap Ultra mass spectrometer (HCT Ultra, PTM discovery) from Bruker Daltonics (Bremen, Germany). All mass spectra were acquired in the mass range *m/z* 100--3000, with a scan speed of 2.1 scan per second.

3.4. Isolation Strategy for Amino Acids and Peptides {#sec3dot4-molecules-20-19819}
----------------------------------------------------

The nature of the target bioactive compounds is influenced by the type of solvent employed. In general, a mixture of solvents was preferred to achieve the selective extraction of interested bioactive compounds from natural products. A preliminary sample was prepared using several solvents with different polarities (ethanol, dichloromethane, carbon tetrachloride, hexane, and *n*-butanol) in order to extract the corresponding phytochemicals from the hellebore extract. It was observed that in fractions with low and medium polarity (dichloromethane, carbon tetrachloride and hexane) lipophilic compounds were usually found, including: fatty acids, terpenes, steroids, peptides, depsipeptides, *etc.* High polarity fractions contained saponins, amino acids, alkaloids, sugars, *etc.* \[[@B24-molecules-20-19819],[@B25-molecules-20-19819],[@B26-molecules-20-19819],[@B33-molecules-20-19819]\].

The solvent from a 50 mL hellebore hydroalcoholic (1.5:1 *v*/*v*; plant extract:alcohol ratio = 1:10) extract was removed under vacuum, the residue was dissolved in water and subsequently extracted with the following solvents: *n*-hexane (S~2~), carbon tetrachloride (S~3~), dichloromethane (S~4~) and *n*-butanol (S~5~). Each of the six organic fractions: S~1~ (ethanolic), S~2~ (hexane), S~3~ (CCl~4~), S~4~ (CH~2~Cl~2~), S~5~ (*n*-butanol), and S~6~ (aqueous) was analyzed by spectroscopic and chromatographic methods.

3.5. Derivatization of Standard Amino Acids {#sec3dot5-molecules-20-19819}
-------------------------------------------

A pre-column derivatization method using PITC (phenylisothiocyanate) or Edman's Reagent was carried out. The obtained phenylisothiocyanate derivatives (PITC-amino acids) were analyzed by reverse-phase high-performance liquid-chromatography \[[@B34-molecules-20-19819],[@B35-molecules-20-19819],[@B36-molecules-20-19819],[@B37-molecules-20-19819],[@B38-molecules-20-19819],[@B39-molecules-20-19819]\]. This method was chosen because the derivatization reagent reacts easily with all amino acids in an alkaline milieu and produces stable products. A sample (1.5 μmol) of standard amino acids is mixed with 1 mL derivatization reagent: pyridine: H~2~O (40:60) and 15 mg PITC. The obtained mixture is heated at 40 °C for 1 h. Then, 1 mL H~2~O is added. The excess of PITC is removed by washing four times with 2 mL of benzene. The aqueous phase is evaporated and dried in vacuum. The residues are dissolved in 1.5 mL methanol and analyzed on HPLC.

3.6. Thionins {#sec3dot6-molecules-20-19819}
-------------

For the separation of thionins, the solvent from a 50 mL hellebore hydroalcoholic extract was removed under vacuum and the resulting residue was extracted successively with petroleum ether (20 mL) and acetone (20 mL). Both isolated fractions---S**~1T~** (petroleum ether) and S**~2T~** (acetone)---were investigated by analytical methods to reveal the presence of the isolated compounds.

3.7. GC-MS Separation Conditions {#sec3dot7-molecules-20-19819}
--------------------------------

The standard analysis conditions were according to instructions from the kit: Oven: 30 °C (hold 1 min) to 40 °C at 30 °C/min (hold 10 min) to 360 °C (hold 1 min); Equilibration time: 1 min; Injection: split 1: 15; 250 °C; 2 µL; Carrier Gas: Helium 1.1 mL/min; 110 °C; Inlet pressure: 5.824 kPa/min; Detector: MS; Mode: Scan Transfer Line Temperature: 250 °C; Analyzer Type: Electron Energy: 70 eV.

3.8. HPLC-DAD Separation Conditions {#sec3dot8-molecules-20-19819}
-----------------------------------

The separation was performed by isocratic elution at Flow Rate: 0.6 mL/min., Col. Temp.: 35 °C and with UV detection (λ = 230 nm). Eluent A: H~2~O--acetonitrile--TFA (94.96% H~2~O, 5% acetonitrile, 0.037% TFA), Eluent B: H~2~O--acetonitrile--TFA (94.96% acetonitrile, 5% H~2~O, 0.037% TFA).

3.9. Mass Spectrometry Analysis {#sec3dot9-molecules-20-19819}
-------------------------------

Tandem mass spectrometry was carried out by collision-induced dissociation (CID) using He as the collision gas. For MS/MS sequencing, the precursor ions were selected within an isolation width of 2 u. Fully automated chip-nano ESI performed in a NanoMate 400 robot incorporating ESI chip technology (Advion BioSciences, Ithaca, NY, USA) coupled on a High Capacity Ion Trap Ultra mass spectrometer (HCT Ultra, PTM discovery, Bruker Daltonics). The robot was controlled and manipulated by the ChipSoft software (Advion BioSciences) operating under Windows. The position of the electrospray chip was adjusted to the sampling cone potential so as to give rise to an optimal transfer of the ionic species into the mass spectrometer. In order to avoid any contamination in all experiments, a glass-coated microtiter plate was used. Five μL aliquots of the working sample solutions were loaded onto the 96-well plate. The robot was programmed to take up the whole volume of sample, followed by 2 μL of air into the pipette tip and then deliver the sample on the inlet side of the microchip. Each nozzle has an internal diameter of 2.5 μm and under the given condition delivered a flow rate of about 200 nL/min. NanoESI process was initiated by applying voltages within 1.5 to 1.8 kV and a head pressure of 0.5--0.7 p.s.i. After spray initialization, infusion parameters were optimized: ESI voltage in pipette tip, voltage and desolvation gas flow. The values of Nano-ESI source parameter, ESI capillary, cone potential and desolvation gas (Nitrogen) were optimized to achieve an efficient ionization and produce the optimum transfer of ions in MS. Measurement parameters were: Capillary voltage 1 kV; Counter electrode voltage (cone voltage) 60 V; Acquisition time 2 min; Scan speed 2.1 scan/s; *m*/*z* 100--3000 mass range. The NanoMate HCT MS system was tuned to operate in the positive ion mode. This technique was chosen, as protein and peptide ionization shows high ionization efficiency in the positive ion mode. The source block, maintained at the constant temperature of 80 °C, provided an optimal desolvation of the generated droplets without a need of a desolvation gas. In all experiments, the desolvation gas was maintained at 30--50 liters per hour. For prevention of any cross contamination or carry-over, the pipette tip was ejected and replaced with a new one, after every sample infusion and MS analysis. All mass spectra were processed by the Data Analysis 3.4 software from Bruker Daltonik (Bremen Germany). Mass spectra were calibrated using sodium iodide as a calibrating agent. The accuracy on the determination of the average mass was 20 ppm, with a resolution of about 4000. Samples were dissolved in methanol at a concentration of about 5 pmol/μL. For an acquisition time of 2 min, the required volume of sample was about 2 pmols, a value which reflects a very high sensitivity analysis.

3.10. Study of the Biological Activity {#sec3dot10-molecules-20-19819}
--------------------------------------

HeLa cells were grown in DMEM-Ham F12 medium (Sigma-Aldrich, Munich, Germany), supplemented with 10% fetal bovine serum (Gibco, Basel, Switzerland) and 1% antibiotic-antimycotic solution (Lonza, Cologne, Germany). They were seeded at a density of 10^4^ cells/well in Hi--Q^4^ 35 mm dishes (Ibidi GmbH, Martinsried, Germany) After cell attachment (2 h), the medium was replaced with a fresh volume supplemented with various concentrations of S~5~ and S~2T~ lyophilized fractions (1, 2 and 4 μg/mL respectively, dissolved in culture medium). For the control group, the medium was aspirated and replaced with fresh standard medium. The dishes were then placed inside the Biostation IM equipment (Nikon Corp., Kawasaki, Japan), a mini-incubator with an incorporated optical system and a CCD camera for timelapse imaging. The cells were monitored for 24 h and images were collected every 10 min. To assess cell viability and proliferation, viable cells and mitoses were counted. For each experimental condition, images were collected from 5 different microscopic fields and the experiments were repeated three times. The wells which contained only the cells, without the added compounds, were considered as control.

4. Conclusions {#sec4-molecules-20-19819}
==============

This study was designed to investigate the chemical composition of extracts of a valuable medicinal plant, the hellebore, with therapeutic effects known since long ago in traditional medicine. The amino acids and peptides contained in a hellebore hydroalcoholic extract were identified and isolated. An appropriate isolation strategy was developed that can be applied for the isolation of such compounds from complex mixtures. The presented results indicate that the new isolation strategy and the feasibility of the developed characterization method show great potential as efficient separation methods for amino acids and peptides from natural products. The methods used in our study to isolate various fractions of the hellebore extract did not affect the antiproliferative activity, as shown by treating HeLa cells and monitoring their behavior by time lapse videomicroscopy.
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